KORRO BIO INC (KRRO) Stock Income Statement
NASDAQ:KRRO - Nasdaq - US5009461089 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.82M | 2.27M | 0.00 | 0.00 | 14.07M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 100.30M | 94.18M | 84.53M | 59.00M | 35.49M | |||
| Research and Development | 69.80M | 63.64M | 57.25M | 42.20M | 23.80M | |||
| Selling, General, and Administrative Expenses | 30.50M | 30.55M | 27.28M | 16.80M | 11.69M | |||
| Operating Income | -95.48M | -91.91M | -84.53M | -59.00M | -35.49M | |||
| Interest Income/Expense | N/A | N/A | N/A | 364.00K | -374.00K | |||
| Other Income/Expense | 8.19M | 8.47M | 3.39M | 976.00K | 13.54M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -87.29M | -83.44M | -81.14M | -58.02M | -21.96M | |||
| Income Tax | 124.00K | 141.00K | 27.00K | 10.00K | 2.00K | |||
| Net Income | -87.41M | -83.58M | -81.17M | -58.03M | -21.96M | |||
| EBITDA | -91.41M | -88.34M | -80.90M | -56.49M | -33.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.44 | -9.37 | -10.13 | -7.25 | -2.74 | |||
| Non GAAP EPS | -9.44 | -9.39 | -83.65 | -116.00 | -2.47 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -1813.13% | -3680.36% | N/A | N/A | -156.09% | |||
| Operating Profit Margin | -1980.44% | -4047.12% | N/A | N/A | -252.30% | |||
All data in USD